Beating Biopharma Manufacturing Bottlenecks with Raman Spectroscopy
A look at the potential of Raman spectroscopy in biopharma – and what else lies on the horizon for this important technique
False
A look at the potential of Raman spectroscopy in biopharma – and what else lies on the horizon for this important technique
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
November 11, 2026
2 min read
The deal adds viral vector, bioconjugation, payload-linker, and advanced drug-delivery capabilities to Lonza’s manufacturing network
November 9, 2026
5 min read
As biologics portfolios expand and average product volumes fall, Miriam Monge asks whether today’s major manufacturing investments offer the flexibility tomorrow’s market will require
November 2, 2026
2 min read
Review examines how PAT, model-based control, reinforcement learning, and digital twins could maintain product quality from perfusion culture through downstream purification
October 22, 2026
5 min read
Rob DiCicco discusses how FDA–industry collaboration is helping sponsors rethink safety reporting, selective safety data collection, and pragmatic clinical trial design.
False
Affiliations:
Specialties:
Areas of Expertise: